Rep. Maura Hirschauer supports HB4203 to broaden cancer screening insurance coverage

Rep. Maura Hirschauer (D-49th) cast her vote in favor of HB4203, which seeks to expand insurance coverage for cancer screenings, during the 104th General Assembly on May 31, 2026. The measure was approved unanimously in the House, 115-0, according to the Illinois House.

The bill summary describes: "INS CD-CANCER SCREENINGS."

This overview offers details clarified from the official bill text.

The legislation updates the Illinois Insurance Code to enhance coverage for designated cancer screenings. It expands the criteria for who counts as "at risk for ovarian cancer" to include those with a high CA-125 blood test result. The bill mandates annual cervical smear or Pap test coverage, yearly prostate screenings for specific groups, and surveillance testing for ovarian cancer, including ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood tests—all without patient cost-sharing. Exemptions exist for certain limited benefit plans and some high-deductible policies associated with health savings accounts. The effective date is Jan. 1, 2028.

The last recorded action for HB4203 was 'Senate Floor Amendment No. 1 House Concurs'.

Hirschauer earned her BA from Colby College.

A member of the Democratic Party, Hirschauer was elected to represent Illinois' 49th House District in 2021, succeeding former state representative Karina Villa.

Legislation in Illinois is processed through a multi-step lawmaking procedure starting with introduction in either chamber, then relies on committee hearings, floor discussions, and approval by both chambers before advancing to the governor. The General Assembly works on a two-year schedule, during which many bills are introduced but only a small number are enacted.